Skip to main content
SpringerLink
Log in

Dual antenatal HIV and syphilis testing cost effective

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2017 US dollars

Reference

  • Rodriguez PJ, et al. Cost-effectiveness of dual maternal HIV and syphilis testing strategies in high and low HIV prevalence countries: a modelling study. The Lancet Global Health : 20 Nov 2020. Available from: URL: https://doi.org/10.1016/S2214-109X(20)30395-8

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dual antenatal HIV and syphilis testing cost effective. PharmacoEcon Outcomes News 867, 12 (2020). https://doi.org/10.1007/s40274-020-7309-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-7309-0

Search

Navigation